BRVE
BRVE
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
1
$89.10M
Insider Sales
0
$0
Total Volume
$89.10M
2 transactions
Net Activity
+$89.10M
Net buying
Sentiment Rating
Strong AccumulationCEO Conviction Index
No Recent Signal
Key Drivers
- •Strong buying bias: purchases represent 100% of total transaction value.
- •Ultra-high accumulation: total purchase value exceeds $10M.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Multiple Insiders
P - Purchase Insiders
$11255.75B total
Quick Actions
BRVE has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.
Over the last 90 days, corporate insiders at BRVE (BRVE) engaged in a total of 2 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 0 were sales. The total volume of insider trading reached $89.10M.
The net insider activity for BRVE shows a net buying bias of $89.10M. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 10.23M shares valued at $11255.66B on Aug 7, 2026.
Braveheart Bio, Inc. (BRVE) Stock Price, News, Quote & History
Braveheart Bio (Nasdaq:BRVE) - Stock Analysis
Braveheart Bio, Inc. Common Stock (BRVE) Historical Data
Braveheart Bio CFO Acquires 27,777 Shares for $500,000. Is This a Signal BRVE IPO Is a Success?
BRVE - Braveheart Bio Inc Stock Price and Quote
Heart drug developer Braveheart Bio surges on public debut after upsized IPO
FAQs About BRVE Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for BRVE.